Screening for trisomy 21 with ultrasonographic determination of biparietal diameter/femur length ratio.
cross_sectional · Level IV
Where this comes from
- Record sourced from PubMed, PMID 2146880.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Ultrasonographic determination of biparietal diameter/femur length ratios performed at 16 or 17 weeks' gestation in fetuses with trisomy 21 were not statistically different from those of 155 normal fetuses. It appears that this test could not be used for screening for trisomy 21.
Medical subject headings
- Down Syndrome
- Femur
- Fetal Diseases
- Parietal Bone